FDA investigates concerns over weight loss medications
By Vuyile Madwantsi | Published Jan 4, 2024
The FDA later approved Semaglutide and Tirzepatide, marketed as Wegovy and Mounjaro, as weight loss treatments in 2021.
By Vuyile Madwantsi | Published Jan 4, 2024
The FDA later approved Semaglutide and Tirzepatide, marketed as Wegovy and Mounjaro, as weight loss treatments in 2021.
By Bang Showbiz | Published Jan 4, 2024
The 52-year-old actress is currently battling stage four cancer but believes that if she can stay alive in the near future, medical advancements will help her to eventually beat the disease.
By The Washington Post | Published Jan 3, 2024
By Bang Showbiz | Published Jan 3, 2024
By The Conversation | Published Jan 2, 2024
By Bang Showbiz | Published Jan 1, 2024
By Bang Showbiz | Published Dec 31, 2023
By AFP | Published Dec 31, 2023
By Lutho Pasiya | Published Dec 29, 2023
By Vuyile Madwantsi | Published Dec 28, 2023
By The Washington Post | Published Dec 28, 2023
By Bang Showbiz | Published Dec 27, 2023
By Viwe Ndongeni-Ntlebi | Published Dec 27, 2023
By Marchelle Abrahams | Published Dec 27, 2023
By AFP | Published Dec 27, 2023
By AFP | Published Dec 26, 2023